New York University

Undergraduate-Led Team Develops Low-Cost Ventilator Aimed at Assisting COVID-19 Patients with Varying Degrees of Lung Failure

20-Apr-2020 8:45 AM EDT, by New York University

Newswise — A team of university students and engineers has developed a low-cost ventilator using off-the-shelf components that is designed to aid patients with varying degrees of lung failure. They are responding to an acute shortage of these life-saving medical devices due to the spread of COVID-19.

NumaVent, a non-profit start-up that includes New York University, Johns Hopkins University, and University of Southern California students and engineers, has created a ventilator at an estimated cost of $500—well below the $25,000-to-$50,000 price tag for conventional ventilators—by drawing from readily available materials, such as: DC Fans, pressure sensors, and solenoid valves. 

Significantly, it aims to aid patients with varying degrees of lung failure with a device that requires minimal training—a crucial feature as healthcare personnel are increasingly taxed. Many “off-the shelf” designs currently in development will only be able to effectively deliver oxygen to patients who are entirely incapable of breathing on their own -- and even these may pose significant safety risks.  

“These ventilators are likely to be rendered useless if a patient can still partially breathe, an overwhelmingly common scenario that radically changes the required functionality,” says Numavent’s President and CEO Daniil Frants, a junior at NYU who is majoring in computer science, mathematics, and physics. “We think we’ve identified the optimal balance between a solution that is too complex to be manufactured quickly, affordably, and at scale, and one that is too simple to be of use to the majority of patients.”

Specifically, NumaVent is designed to accommodate a wide range of patient breathing patterns through an array of sensors and can be used for virtually any patient requiring ventilation due to complications from COVID-19. 

The team, which is currently seeking funding for its work, is now prototyping and testing its design in order to prepare it for large-scale manufacturing; it is also in the process of seeking Emergency Use Authorization from the FDA.  

Approximately 30 percent of patients hospitalized with COVID-19 symptoms will require mechanical ventilation, according to some estimates. Meanwhile, countries around the world are dealing with a shortage of ventilators, which will soon become critical. It is estimated that the US alone will need 960,000 ventilators, while the current projections put global demand at 22 million ventilators.   

Frants, a social innovations entrepreneur, sought to create an affordable ventilator from the ground up, attracting like-minded students and engineers to help develop the technology.  

Within two weeks NumaVent had put together a significantly simplified design for a ventilator built from off-the-shelf components. 

NumaVent has received a grant of $25,000 from Differential Ventures to prototype and test the device. The team plans to open-source the ventilator and provide it at-cost to medical institutions and governments.  

Specific Features of NumaVent

  1. NumaVent has three pressure sensors, a temperature sensor, and a flow sensor placed in various locations in the device, so the ventilator can respond appropriately to the patient’s own breathing patterns. This feature allows the ventilator to assist patients who do not need full mechanical ventilation, and also eliminates a slew of safety issues, including rupturing the alveoli. 
  1. A series of electrical and mechanical failsafes, ranging from the inclusion of the standard PEEP valve to response protocols involving the aforementioned sensors, address the vast majority of threats to patient safety that could arise during mechanical ventilation. 
  1. A turbine-based driver allows for precise flow and pressure control that other proposed drivers cannot provide (particularly misguided is the popular BVM design). This allows NumaVent to respond to a much greater range of patient needs. 
  1. Due to the flexibility of its turbine-based system, NumaVent can support a full range of breathing patterns by considering parameters such as inspiration/expiration ratio, lung compliance, and patient responsiveness. 

Another vital, yet often overlooked aspect of effective mechanical ventilation is proper use by trained medical personnel. Even if the ventilator shortage were met in full right now, there are not nearly enough medical personnel properly trained in intensive care to operate the required number of machines. The team is building an intuitive user interface that will minimize the amount of specialty training needed. Its intent is for staff with only basic training in intensive care to be able to operate NumaVent.




Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.


Showing results

110 of 2454

close
1.45734